Both medications can also promote weight loss in individuals with Type 2 diabetes who are obese or overweight, although they are not approved as a primary treatment for weight management
Theyre known to: Suppress the immune system by impairing white blood cell activity Disrupt cellular communication and hormone signaling Damage mitochondria, reducing energy production Increase oxidative stress by generating reactive oxygen species (ROS) Inhibit protein synthesis and impair enzyme function Cross the blood-brain barrier, affecting cognition and mood Because they are lipophilic (fat-loving), mycotoxins tend to be stored in fat cells, making them particularly stubborn to eliminate
Both medications work through entirely different mechanisms and are metabolised via separate pathways in the body, meaning they do not typically interfere with each other's effectiveness or safety profile
Durvi Patel, MD , who integrates this advanced treatment into a comprehensive wellness program
The Food and Drug Administration (FDA) announced that all doses of tirzepatide, the active ingredient in Mounjaro, are back in supply